首页> 外文期刊>DNA and Cell Biology >Downregulation of miR-335-5p by Long Noncoding RNA ZEB1-AS1 in Gastric Cancer Promotes Tumor Proliferation and Invasion
【24h】

Downregulation of miR-335-5p by Long Noncoding RNA ZEB1-AS1 in Gastric Cancer Promotes Tumor Proliferation and Invasion

机译:在胃癌中长时间的NOODING RNA Zeb1-AS1下调miR-335-5p的下调促进了肿瘤增殖和侵袭

获取原文
获取原文并翻译 | 示例
           

摘要

Recently, long noncoding RNAs (lncRNAs) have emerged as new gene regulators and prognostic biomarkers in several cancers, including gastric cancer (GC). In this study, we investigate the role of lncRNA ZEB1 antisense1 (ZEB1-AS1) on GC progression. In the present study, we found that ZEB1-AS1 expression was upregulated in GC tissues and cell lines. High ZEB1-AS1 expression was significantly correlated with advanced TNM stage, lymph node metastasis, and poor overall survival in GC patients. ZEB1-AS1 suppression reduced GC cell proliferation and invasion in vitro . Tumor formation assay in nude mice showed that ZEB1-AS1 inhibition suppressed GC cell growth. Quantitative real-time PCR showed that miR-335-5p expression was downregulated and negatively correlated with ZEB1-AS1 expression in GC tissues. And miR-335-5p expression was directly regulated by ZEB1-AS1. Furthermore, we found that inhibition of miR-335-5p abrogated the suppression of proliferation and invasion of GC cells induced by ZEB1-AS1 depletion. Collectively, ZEB1-AS1 is critical for the proliferation and invasion of GC cells by regulating miR-335-5p. Our findings indicated that ZEB1-AS1 might offer potential novel therapeutic targets for GC patients.
机译:最近,长时间的NOODING RNA(LNCRNA)作为新的基因调节因子和几种癌症中的预后生物标志物,包括胃癌(GC)。在这项研究中,我们研究了LNCRNA Zeb1 Antisense1(Zeb1-AS1)对GC进展的作用。在本研究中,我们发现Zeb1-AS1表达在GC组织和细胞系中升高。高Zeb1-AS1表达与高级TNM阶段,淋巴结转移以及GC患者的差的整体存活率显着相关。 Zeb1-AS1抑制降低了GC细胞增殖和体外侵袭。裸鼠中的肿瘤形成测定表明Zeb1-AS1抑制抑制了GC细胞生长。定量实时PCR显示MIR-335-5P表达下调并与GC组织中的Zeb1-As1表达呈负相关。 MiR-335-5P表达直接受Zeb1-AS1调节。此外,我们发现miR-335-5p的抑制废除了Zeb1-As1耗尽诱导的GC细胞的增殖和侵袭。综合地,Zeb1-AS1对于通过调节miR-335-5p来对GC细胞的增殖和侵袭至关重要。我们的研究结果表明,Zeb1-AS1可能为GC患者提供潜在的新疗法靶标。

著录项

  • 来源
    《DNA and Cell Biology》 |2018年第1期|共7页
  • 作者单位

    Department of Gastroenterology The First Affiliated Hospital of Xinxiang Medical University Weihui Henan China.;

    Department of Gastroenterology The First Affiliated Hospital of Xinxiang Medical University Weihui Henan China.;

    Department of Gastroenterology The First Affiliated Hospital of Xinxiang Medical University Weihui Henan China.;

    Department of Gastrointestinal Surgery The First Affiliated Hospital of Xinxiang Medical University Weihui Henan China.;

    Department of Gastroenterology The First Affiliated Hospital of Xinxiang Medical University Weihui Henan China.;

    Department of Gastroenterology The First Affiliated Hospital of Xinxiang Medical University Weihui Henan China.;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 other
  • 中图分类 细胞遗传学;
  • 关键词

    long noncoding RNA; ZEB1-AS1; gastric cancer; miR-335-5p; progression;

    机译:长的非致rna;zeb1-as1;胃癌;mir-335-5p;进展;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号